IgA Nephropathy Risk Score

Estimate the risk of renal function decline in IgA nephropathy using the International IgA Nephropathy Prediction Tool, incorporating clinical and pathological MEST-C features.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Estimate the risk of renal function decline in IgA nephropathy using the International IgA Nephropathy Prediction Tool, incorporating clinical and pathological MEST-C features

Each component has a specific meaning:

  • International IgA Nephropathy Prediction Tool — The international iga nephropathy prediction tool recorded for the scenario being assessed.
  • Incorporating clinical — The incorporating clinical recorded for the scenario being assessed.
  • Pathological MEST-C features — The pathological mest-c features recorded for the scenario being assessed.

Note: Interpret the iga nephropathy risk result against the thresholds and context described above.

How to Use

Enter the International IgA Nephropathy Prediction Tool, incorporating clinical, pathological MEST-C features for the scenario you are assessing. Estimate the risk of renal function decline in IgA nephropathy using the International IgA Nephropathy Prediction Tool, incorporating clinical and pathological MEST-C features. Use the iga nephropathy risk result to inform your calculation.

Frequently Asked Questions